tiprankstipranks
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE:DNA
US Market
DNA
Ginkgo Bioworks Holdings
RESEARCH TOOLSreports
Want to see DNA full AI Analyst Report?

Ginkgo Bioworks Holdings (DNA) Ratios

2,304 Followers

Ginkgo Bioworks Holdings Ratios

DNA's free cash flow for Q1 2026 was $0.18. For the 2026 fiscal year, DNA's free cash flow was decreased by $ and operating cash flow was $-3.67. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.15 4.92 5.62 6.11 8.38
Quick Ratio
 5.15 4.92 5.62 6.11 8.36
Cash Ratio
 1.81 1.74 5.24 5.76 7.61
Solvency Ratio
 -0.36 -0.42 -0.73 -1.45 -2.54
Operating Cash Flow Ratio
 -2.09 -1.78 -2.98 -1.80 -1.46
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -179.97M$ -139.27M$ -58.65M$ 433.56M$ 647.03M
Leverage Ratios
Debt-to-Assets Ratio
 0.40 0.37 0.34 0.14 0.17
Debt-to-Equity Ratio
 0.93 0.82 0.65 0.22 0.25
Debt-to-Capital Ratio
 0.48 0.45 0.40 0.18 0.20
Long-Term Debt-to-Capital Ratio
 0.48 0.45 0.00 0.00 0.00
Financial Leverage Ratio
 2.33 2.20 1.92 1.52 1.46
Debt Service Coverage Ratio
 0.00 0.00 -5.15K -8.83K -19.29K
Interest Coverage Ratio
 0.00 0.00 -5.95K -9.29K -20.84K
Debt to Market Cap
 0.82 0.91 0.00 0.00 0.00
Interest Debt Per Share
 6.90 7.52 9.01 4.93 10.56
Net Debt to EBITDA
 -1.29 -0.98 0.19 0.86 0.42
Profitability Margins
Gross Profit Margin
74.97%81.48%83.02%78.52%57.25%
EBIT Margin
-209.03%-184.30%-241.11%-355.07%-444.06%
EBITDA Margin
-145.85%-149.63%-213.35%-326.62%-431.16%
Operating Profit Margin
-210.66%-185.29%-246.54%-343.76%-462.41%
Pretax Profit Margin
-211.50%-184.30%-241.15%-355.11%-444.08%
Net Profit Margin
-215.41%-183.81%-240.94%-355.08%-440.63%
Continuous Operations Profit Margin
-210.79%-183.81%-240.94%-355.08%-440.93%
Net Income Per EBT
101.85%99.73%99.91%99.99%99.22%
EBT Per EBIT
100.40%99.47%97.81%103.30%96.04%
Return on Assets (ROA)
-29.46%-27.93%-39.71%-53.61%-82.89%
Return on Equity (ROE)
-57.31%-61.50%-76.39%-81.38%-121.23%
Return on Capital Employed (ROCE)
-31.22%-30.80%-44.07%-57.57%-93.35%
Return on Invested Capital (ROIC)
-31.12%-30.71%-43.05%-56.90%-91.55%
Return on Tangible Assets
-30.93%-29.43%-41.92%-58.23%-88.89%
Earnings Yield
-66.28%-67.87%-107.34%-27.22%-74.26%
Efficiency Ratios
Receivables Turnover
 7.13 7.08 10.12 14.05 5.69
Payables Turnover
 2.17 2.98 2.72 5.79 19.54
Inventory Turnover
 0.00 0.00 0.00 1.17K 46.80
Fixed Asset Turnover
 0.27 0.32 0.38 0.64 0.66
Asset Turnover
 0.14 0.15 0.16 0.15 0.19
Working Capital Turnover Ratio
 0.40 0.39 0.34 0.24 0.33
Cash Conversion Cycle
 -117.11 -70.81 -98.08 -36.72 53.32
Days of Sales Outstanding
 51.18 51.54 36.08 25.98 64.20
Days of Inventory Outstanding
 0.00 0.00 0.00 0.31 7.80
Days of Payables Outstanding
 168.30 122.35 134.16 63.01 18.68
Operating Cycle
 51.18 51.54 36.08 26.29 72.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.79 -3.08 -6.16 -6.09 -6.01
Free Cash Flow Per Share
 -3.08 -3.22 -7.36 -6.93 -7.26
CapEx Per Share
 0.29 0.14 1.21 0.84 1.25
Free Cash Flow to Operating Cash Flow
 1.10 1.04 1.20 1.14 1.21
Dividend Paid and CapEx Coverage Ratio
 -9.60 -22.32 -5.11 -7.24 -4.82
Capital Expenditure Coverage Ratio
 -9.60 -22.32 -5.11 -7.24 -4.82
Operating Cash Flow Coverage Ratio
 -0.40 -0.41 -0.68 -1.23 -0.57
Operating Cash Flow to Sales Ratio
 -1.17 -1.01 -1.41 -1.18 -0.53
Free Cash Flow Yield
-36.39%-38.78%-74.98%-10.25%-10.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.51 -1.47 -0.93 -3.67 -1.35
Price-to-Sales (P/S) Ratio
 3.56 2.71 2.24 13.05 5.93
Price-to-Book (P/B) Ratio
 1.04 0.91 0.71 2.99 1.63
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.75 -2.58 -1.33 -9.75 -9.31
Price-to-Operating Cash Flow Ratio
 -2.77 -2.69 -1.59 -11.10 -11.24
Price-to-Earnings Growth (PEG) Ratio
 -0.03 0.03 0.02 0.06 0.20
Price-to-Fair Value
 1.04 0.91 0.71 2.99 1.63
Enterprise Value Multiple
 -3.74 -2.79 -0.86 -3.14 -0.95
Enterprise Value
 770.49M 710.73M 415.76M 2.58B 1.96B
EV to EBITDA
 -3.74 -2.79 -0.86 -3.14 -0.95
EV to Sales
 5.45 4.18 1.83 10.24 4.11
EV to Free Cash Flow
 -4.20 -3.98 -1.09 -7.66 -6.44
EV to Operating Cash Flow
 -4.64 -4.15 -1.30 -8.72 -7.78
Tangible Book Value Per Share
 6.62 8.14 12.40 19.89 37.32
Shareholders’ Equity Per Share
 7.44 9.17 13.80 22.61 41.41
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 <0.01 <0.01 <0.01
Revenue Per Share
 2.37 3.07 4.38 5.18 11.39
Net Income Per Share
 -5.11 -5.64 -10.54 -18.40 -50.20
Tax Burden
 1.02 1.00 1.00 1.00 0.99
Interest Burden
 1.01 1.00 1.00 1.00 1.00
Research & Development to Revenue
 1.58 1.43 1.87 2.31 2.20
SG&A to Revenue
 1.22 1.08 1.08 1.53 2.99
Stock-Based Compensation to Revenue
 0.54 0.48 0.49 0.91 4.04
Income Quality
 0.56 0.55 0.58 0.33 0.12
Currency in USD